TPG-backed clinical research firm Novotech completes $760m financing round

Clinical research and testing provider Novotech Health Holdings Pte., which is backed by PE firm TPG, has announced the completion of a financing round of $760 million (about A$1.06 billion) from a group of global investors.

The financing round comprises a $255 million private placement and a $505 million refinancing transaction.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter